AAM 2022 Report on Generic and Biosim Savings for 2021

It’s no surprise that the use of generic drugs saves consumers and health plans big money.  Now, add the savings being achieved from biosimilars (expected to increase significantly over the next year or two) and the amount is almost staggering! The just-released report, which can be found here, provides details that support the findings that […]

Read More